InvaTech Pharma Solutions LLC and Elysium Pharmaceuticals Ltd.
11
Christine M. Gravelle
02/13/2025
04/03/2025
Yes
v
Assigned to: Judge Christine M. Gravelle Chapter 11 Voluntary Asset |
|
Debtor InvaTech Pharma Solutions LLC
40 C Cotters Lane, Suite #A East Brunswick, NJ 08816 MIDDLESEX-NJ Tax ID / EIN: 27-2411999 dba Inva Tech Pharma Solutions LLC dba Inva-Tech Pharma Solutions LLC |
represented by |
Donald W Clarke
Genova Burns LLC 110 Allen Road Ste 304 Basking Ridge, NJ 07920 973-467-2700 Email: dclarke@genovaburns.com Susan Long
Genova Burns LLC 494 Broad Street Newark, NJ 07102 973-535-7119 Email: slong@genovaburns.com Daniel Stolz
Genova Burns LLC 110 Allen Road Suite 304 Ste 304 Basking Ridge, NJ 07920 973-467-2700 Email: dstolz@genovaburns.com |
Debtor In Possession Elysium Pharmaceuticals Ltd.
MIDDLESEX-NJ |
represented by |
Christopher D Loizides
Loizides, P.A. 1225 King St. Suite 800 Wilmington, DE 19801 302-654-0248 Email: loizides@loizides.com |
U.S. Trustee U.S. Trustee
US Dept of Justice Office of the US Trustee One Newark Center Ste 2100 Newark, NJ 07102 (973) 645-3014 |
represented by |
Lauren Bielskie
DOJ-Ust One Newark Center Suite 2100 Newark, NJ 07102 973-645-2939 Email: lauren.bielskie@usdoj.gov Samantha Lieb
DOJ-Ust One Newark Center Suite 2100 Newark, NJ 07102 202-604-2499 Email: samantha.lieb2@usdoj.gov |
| Date Filed | # | Docket Text |
|---|---|---|
| 04/02/2025 | 68 | BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 04/02/2025. (Admin.) |
| 04/02/2025 | 67 | BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 04/02/2025. (Admin.) |
| 04/02/2025 | 66 | BNC Certificate of Notice - Order No. of Notices: 1. Notice Date 04/02/2025. (Admin.) |
| 04/02/2025 | 65 | Notice of Appearance and Request for Service of Notice filed by Christopher D Loizides on behalf of Elysium Pharmaceuticals Ltd.. (Loizides, Christopher) (Entered: 04/02/2025) |
| 04/02/2025 | 64 | Application for Attorney Robert P. Goe to Appear Pro Hac Vice Filed by Christopher D Loizides on behalf of Elysium Pharmaceuticals Ltd.. Objection deadline is 4/9/2025. (Attachments: # 1 Certification # 2 Proposed Order # 3 Certificate of Service) (Loizides, Christopher) (Entered: 04/02/2025) |
| 04/02/2025 | Hearing Rescheduled from 4/8/2025. (related document:6 Notice of Hearing for: Status Conference. (related document:1 Chapter 11 Voluntary Petition Filed by Daniel Stolz on behalf of InvaTech Pharma Solutions LLC. Chapter 11 Debtors Exclusive Right to File a Plan Expires on 06/13/2025. filed by Debtor InvaTech Pharma Solutions LLC). The following parties were served: Debtor, Debtor's Attorney, Trustee, and US Trustee. Hearing scheduled for 4/8/2025 at 2:00 PM, CMG - Courtroom 3, Trenton.) Hearing scheduled for 4/22/2025 at 2:00 PM, CMG - Courtroom 3, Trenton. (rms) (Entered: 04/02/2025) | |
| 04/01/2025 | 63 | Certificate of Service (related document:60 Order (Generic), 61 Order (Generic), 62 Order on Motion for Continuation of Utility Service) filed by Daniel Stolz on behalf of InvaTech Pharma Solutions LLC. (Stolz, Daniel) (Entered: 04/01/2025) |
| 03/31/2025 | 62 | Final Order (I) Prohibiting Utility Companies from Discontinuing, Altering, or Refusing Service on Account of Prepetition Invoices, and (II) Deeming Utility Companies to Have Adequate Assurance of Future Payment Pursuant to 11 U.S.C. §§ 105(a) and 366 (Related Doc # 20). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 3/31/2025. (rms) (Entered: 03/31/2025) |
| 03/31/2025 | 61 | Second Interim Order Authorizing the Debtor to Maintain Existing Cash Management Accounts (related document:21 Motion re: for Authorization to Maintain Existing Cash Management System Filed by Susan Long on behalf of InvaTech Pharma Solutions LLC.. (Attachments: # 1 Application for Authorization to Maintain Existing Cash Management System # 2 Proposed Order Authorizing the Debtor to Maintain Existing Cash Management System) filed by Debtor InvaTech Pharma Solutions LLC). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 3/31/2025. (rms) (Entered: 03/31/2025) |
| 03/31/2025 | 60 | Third Interim Order Authorizing the Use of Cash Collateral, Granting Adequate Protection, Granting Related Relief, and Scheduling a Final Hearing (related document:19 Motion to Use Cash Collateral Filed by Donald W Clarke on behalf of InvaTech Pharma Solutions LLC.. (Attachments: # 1 Application for the Entry of Interim and Final Orders Under Sections 361 and 363 of the Bankruptcy Code Authorizing the Use of Cash Collateral, Granting Adequate Protection, Granting Related Relief, and Scheduling a Final Hearing # 2 Exhibit A # 3 Exhibit B # 4 Exhibit C # 5 Exhibit D # 6 Proposed Order Interim Order Authorizing the Use of Cash Collateral, Granting Adequate Protection, Granting Related Relief, and Scheduling a Second Interim Hearing and a Final Hearing) filed by Debtor InvaTech Pharma Solutions LLC). Service of notice of the entry of this order pursuant to Rule 9022 was made on the appropriate parties. See BNC Certificate of Notice. Signed on 3/31/2025. (rms) (Entered: 03/31/2025) |